Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

2.

Associations between Chlamydophila infections, schizophrenia and risk of HLA-A10.

Fellerhoff B, Laumbacher B, Mueller N, Gu S, Wank R.

Mol Psychiatry. 2007 Mar;12(3):264-72. Epub 2006 Nov 14.

PMID:
17102800
3.

Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K, Caggiari L, Lettini AA, Dal Cin E, Ieri R, Freschi M, Villa E, Boiocchi M, Dolcetti R.

J Natl Cancer Inst. 2004 Apr 21;96(8):586-94.

PMID:
15100336
4.
6.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

7.

Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.

Velakoulis D, Wood SJ, Wong MT, McGorry PD, Yung A, Phillips L, Smith D, Brewer W, Proffitt T, Desmond P, Pantelis C.

Arch Gen Psychiatry. 2006 Feb;63(2):139-49.

PMID:
16461856
8.

Pyoderma gangrenosum and Chlamydia pneumoniae infection in a diabetic man: pathogenic role or coincidence?

Vannucci SA, Mitchell WM, Stratton CW, King LE Jr.

J Am Acad Dermatol. 2000 Feb;42(2 Pt 1):295-7.

PMID:
10642692
9.

Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.

Romano Carratelli C, Nuzzo I, Cozzolino D, Bentivoglio C, Paolillo R, Rizzo A.

Int Immunopharmacol. 2006 May;6(5):848-53. Epub 2005 Nov 28.

PMID:
16546716
10.

Chlamydia trachomatis infections and the risk of ectopic pregnancy in Khon Kaen women.

Pientong C, Ekalaksananan T, Wonglikitpanya N, Swadpanich U, Kongyingyoes B, Kleebkaow P.

J Obstet Gynaecol Res. 2009 Aug;35(4):775-81. doi: 10.1111/j.1447-0756.2009.01012.x.

PMID:
19751341
11.

Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.

Dunham JS, Deakin JF, Miyajima F, Payton A, Toro CT.

J Psychiatr Res. 2009 Sep;43(14):1175-84. doi: 10.1016/j.jpsychires.2009.03.008. Epub 2009 Apr 18.

PMID:
19376528
12.

Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients.

Wszola M, Kwiatkowski A, Nosek R, Podsiadly E, Meszaros J, Danielewicz R, Lisik W, Ostrowski K, Chmura A, Adadyński L, Paczek L, Durlik M, Tylewska-Wierzbanowska S, Rowiński W.

Transplant Proc. 2006 Jan-Feb;38(1):31-4.

PMID:
16504656
13.

Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.

Morrato EH, Dodd S, Oderda G, Haxby DG, Allen R, Valuck RJ.

Clin Ther. 2007 Jan;29(1):183-95.

PMID:
17379060
14.

Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion.

Barr EL, Ouburg S, Igietseme JU, Morré SA, Okwandu E, Eko FO, Ifere G, Belay T, He Q, Lyn D, Nwankwo G, Lillard JW Jr, Black CM, Ananaba GA.

J Microbiol Immunol Infect. 2005 Aug;38(4):244-54.

PMID:
16118671
15.
16.

Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.

Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1164-9. Epub 2007 Mar 21.

PMID:
17459548
18.

Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms.

Numata S, Ueno S, Iga J, Yamauchi K, Hongwei S, Ohta K, Kinouchi S, Shibuya-Tayoshi S, Tayoshi S, Aono M, Kameoka N, Sumitani S, Tomotake M, Kaneda Y, Taniguchi T, Ishimoto Y, Ohmori T.

Neurosci Lett. 2006 Jun 19;401(1-2):1-5. Epub 2006 Mar 14.

PMID:
16533563
19.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
20.

Susceptibility of human monocyte-macrophages to Chlamydia pneumoniae infection in vitro is highly variable and associated with levels of soluble CD14 and C. pneumoniae IgA and human HSP-IgG antibodies in serum.

Poikonen K, Lajunen T, Silvennoinen-Kassinen S, Paldanius M, Leinonen M, Saikku P.

Scand J Immunol. 2008 Mar;67(3):279-84. doi: 10.1111/j.1365-3083.2007.02061.x. Epub 2008 Jan 10.

Supplemental Content

Support Center